Amedeo Smart

Free Medical Literature Service

 

Amedeo

Peptic Ulcer
  Free Subscription

Articles published in
Scand J Gastroenterol
    July 2025
  1. ZHANG YY, Zhang QX, Zhuang ZH, Lian TT, et al
    Comparison of the Rockall Score and Revised Rockall Score for predicting outcomes in nonvariceal upper gastrointestinal bleeding.
    Scand J Gastroenterol. 2025 Jul 29:1-31. doi: 10.1080/00365521.2025.2538758.
    >> Share

    May 2025
  2. SANDBERG-JANZON A, Karling P
    Prescription of NSAIDs and proton pump inhibitors are associated with increased faecal calprotectin levels in patients with functional bowel disorder: an observational study.
    Scand J Gastroenterol. 2025 May 29:1-8. doi: 10.1080/00365521.2025.2512368.
    >> Share

  3. WALDUM H, Modlin I
    The central role of gastrin in Helicobacter pylori gastric carcinogenesis.
    Scand J Gastroenterol. 2025 May 24:1-12. doi: 10.1080/00365521.2025.2509094.
    >> Share

    March 2025
  4. JIA X, Hu HQ
    Research progress of MUC family in esophageal mucosal barrier of gastroesophageal reflux disease.
    Scand J Gastroenterol. 2025 Mar 19:1-11. doi: 10.1080/00365521.2025.2479566.
    >> Share

  5. LI Y, Zhu S, Liu Y, He D, et al
    Economic evaluation of preventing gastric cancer by eliminating Helicobacter pylori infection in China.
    Scand J Gastroenterol. 2025 Mar 4:1-9. doi: 10.1080/00365521.2025.2473020.
    >> Share

    January 2025
  6. YARKAC A, Bozkurt S, Kose A, Buyurgan CS, et al
    AS score: a novel score for predicting clinical outcomes in upper gastrointestinal bleeding.
    Scand J Gastroenterol. 2025 Jan 31:1-6. doi: 10.1080/00365521.2025.2459237.
    >> Share

  7. LIN S, Chen Z, Jiang W, Zhu Y, et al
    Exploring esophagogastric junction morphology and contractile integral: implications for refractory gastroesophageal reflux disease pathophysiology.
    Scand J Gastroenterol. 2025 Jan 7:1-6. doi: 10.1080/00365521.2025.2450042.
    >> Share

    December 2024
  8. WALDUM H, Fossmark R
    Eradication of Helicobacter pylori by a potassium-competitive acid blocker alone?
    Scand J Gastroenterol. 2024 Dec 26:1-3. doi: 10.1080/00365521.2024.2444477.
    >> Share

    November 2024
  9. LEE HT, Hong H, Lee AY, Park SJ, et al
    Endoscopic indicators of insulin resistance: associations with erosive esophagitis and regular arrangement of collecting venules (RAC).
    Scand J Gastroenterol. 2024 Nov 25:1-8. doi: 10.1080/00365521.2024.2431054.
    >> Share

  10. YASUDA T, Yagi N, Omatsu T, Kitae H, et al
    High neutrophil-to-lymphocyte ratio at Helicobacter pylori eradication increases the risk of eradication failure and post-eradication gastric cancer.
    Scand J Gastroenterol. 2024 Nov 14:1-12. doi: 10.1080/00365521.2024.2428280.
    >> Share

    September 2024
  11. JIANG G, Luo M, Zheng P, Cong Y, et al
    Eradication rate and safety of vonoprazan-amoxicillin dual therapy for helicobacter pylori eradication: a randomized controlled trial.
    Scand J Gastroenterol. 2024 Sep 22:1-5. doi: 10.1080/00365521.2024.2407898.
    >> Share

  12. UCHIYAMA K, Ando T, Kishimoto E, Nishimura T, et al
    Correlation of gastrointestinal symptom rating scale and frequency scale for the symptoms of gastroesophageal reflux disease with endoscopic findings.
    Scand J Gastroenterol. 2024 Sep 20:1-9. doi: 10.1080/00365521.2024.2406537.
    >> Share

  13. DAETHADOTTIR SM, Ingason AB, Hreinsson JP, Bjornsson ES, et al
    Comparison of gastrointestinal bleeding in patients with and without liver cirrhosis.
    Scand J Gastroenterol. 2024;59:1081-1086.
    >> Share

    May 2024
  14. SHINOZAKI S, Osawa H, Miura Y, Sakamoto H, et al
    The presence of hiatal hernia is a significant predictor for symptomatic recurrence after cessation of vonoprazan therapy for gastroesophageal reflux disease: a long-term observational study.
    Scand J Gastroenterol. 2024 May 31:1-7. doi: 10.1080/00365521.2024.2355351.
    >> Share

  15. VISNES ES, Hallan A, Bomme M, Holmberg D, et al
    Prevalence and risk factors of gastro-oesophageal reflux symptoms among adolescents, the HUNT study.
    Scand J Gastroenterol. 2024 May 16:1-5. doi: 10.1080/00365521.2024.2349646.
    >> Share

  16. ZHOU X, Duan H, Li Q, Wang Q, et al
    Efficacy and safety of potassium-competitive acid inhibitors in the treatment of gastroesophageal reflux: a systematic review and meta-analysis.
    Scand J Gastroenterol. 2024 May 14:1-10. doi: 10.1080/00365521.2024.2349638.
    >> Share

  17. REHFELD JF
    The cckOMA syndrome and its relation to the Zollinger-Ellison syndrome: a diagnostic challenge.
    Scand J Gastroenterol. 2024;59:533-542.
    >> Share

    February 2024
  18. JAAN A, Sarfraz Z, Farooq U, Gutman J, et al
    Nonvariceal upper gastrointestinal bleeding in COVID-19 patients: insights from the National Inpatient Sample.
    Scand J Gastroenterol. 2024 Feb 2:1-8. doi: 10.1080/00365521.2024.2310161.
    >> Share

    January 2024
  19. HU RF, Xiao JL, Fan LJ
    Do people who have had a cholecystectomy have a lower incidence of Helicobacter pylori infection?
    Scand J Gastroenterol. 2024 Jan 30:1-2. doi: 10.1080/00365521.2024.2304587.
    >> Share

    December 2023
  20. ALLO G, Gulcicegi D, Gillessen J, Kasper P, et al
    Timing of endoscopy in patients with elevated lactate levels and acute upper gastrointestinal bleeding; a retrospective comparative study.
    Scand J Gastroenterol. 2023 Dec 27:1-6. doi: 10.1080/00365521.2023.2298355.
    >> Share

    November 2023
  21. WAN L, Zuo HZ, Li DW
    Mendelian randomization analysis reveals the impact of physical and occupational activities on the risk of gastroesophageal reflux disease and Barrett's esophagus.
    Scand J Gastroenterol. 2023 Nov 27:1-8. doi: 10.1080/00365521.2023.2287416.
    >> Share

    October 2023
  22. FERREIRA AI, Lima Capela T, Macedo Silva V, Xavier S, et al
    Gastric dysplasia in random biopsies: the influence of Helicobacter pylori infection and alcohol consumption in the presence of a lesion.
    Scand J Gastroenterol. 2023 Oct 23:1-8. doi: 10.1080/00365521.2023.2272563.
    >> Share

    September 2023
  23. FOSSMARK R, Lirhus SS, Hoivik ML
    The impact of proton pump inhibitors on the course of ulcerative colitis: a cohort study of over 10,000 newly diagnosed patients in Norway.
    Scand J Gastroenterol. 2023 Sep 8:1-6. doi: 10.1080/00365521.2023.2255710.
    >> Share

  24. YU JH, Lee JW, Seo JY, Park JS, et al
    Factors influencing re-bleeding after trans-arterial embolization for endoscopically unmanageable peptic ulcer bleeding.
    Scand J Gastroenterol. 2023 Sep 6:1-9. doi: 10.1080/00365521.2023.2253346.
    >> Share

    July 2023
  25. KATO I, Minkevitch J, Sun J
    Oncogenic potential of Campylobacter infection in the gastrointestinal tract: narrative review.
    Scand J Gastroenterol. 2023;58:1453-1465.
    >> Share

    March 2023
  26. LIU D, Xu L, Chen L, Hu J, et al
    TRPV1 is a risk factor for sleep disturbance in patients with gastro-oesophageal reflux disease: a case control study.
    Scand J Gastroenterol. 2023 Mar 16:1-12. doi: 10.1080/00365521.2023.2190438.
    >> Share

    February 2023
  27. PROSENZ J, Stattermayer MS, Riedl F, Maieron A, et al
    Adherence to guidelines in patients with non-variceal upper gastrointestinal bleeding (UGIB) - results from a retrospective single tertiary center registry.
    Scand J Gastroenterol. 2023 Feb 28:1-7. doi: 10.1080/00365521.2023.2183734.
    >> Share

  28. NESS-JENSEN E, Hammer A, Hopstock LA
    Trends in gastro-oesophageal reflux in a Norwegian general population: the Tromso Study 1979-2016.
    Scand J Gastroenterol. 2023 Feb 27:1-4. doi: 10.1080/00365521.2023.2183733.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016